CAPMATINIB | CAPMATINIB | ATC L01EX17
ANTINEOPLASTIC TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) MET KINASE INHIBITOR | ORAL | Tmax 1.5 HOUR F 70 PERCENT VD 164 LITER PPB 96 PERCENT Cl 24 LITER / HOUR HT 6.5 HOUR SOLUBILITY LOW SOLUBILITY IN WATER | MET | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |